Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 31 Records) |
Query Trace: CALU[original query] |
---|
Polymorphisms in vitamin K-dependent gamma-carboxylation-related genes influence interindividual variability in plasma protein C and protein S activities in the general population. International journal of hematology 2006 Dec 84 (5): 387-97. Kimura R, Kokubo Y, Miyashita K, Otsubo R, Nagatsuka K, Otsuki T, Sakata T, Nagura J, Okayama A, Minematsu K, Naritomi H, Honda S, Sato K, Tomoike H, Miyata T |
Genotypes of vitamin K epoxide reductase, gamma-glutamyl carboxylase, and cytochrome P450 2C9 as determinants of daily warfarin dose in Japanese patients. Thrombosis research 2007 120 (2): 181-6. Kimura Rina, Miyashita Kotaro, Kokubo Yoshihiro, Akaiwa Yasuhisa, Otsubo Ryoichi, Nagatsuka Kazuyuki, Otsuki Toshiho, Okayama Akira, Minematsu Kazuo, Naritomi Hiroaki, Honda Shigenori, Tomoike Hitonobu, Miyata Toshiyu |
Association of warfarin dose with genes involved in its action and metabolism. Human genetics 2007 Mar 121 (1): 23-34. Wadelius Mia, Chen Leslie Y, Eriksson Niclas, Bumpstead Suzannah, Ghori Jilur, Wadelius Claes, Bentley David, McGinnis Ralph, Deloukas Pan |
The genetic interaction between VKORC1 c1173t and calumenin a29809g modulates the anticoagulant response of acenocoumarol. Journal of thrombosis and haemostasis : JTH 2007 Aug 5 (8): 1701-6. González-Conejero R, Corral J, Roldán V, Ferrer F, Sánchez-Serrano I, Sánchez-Blanco J J, Marín F, Vicente |
Genetic determinants of warfarin dosing in the Han-Chinese population. Pharmacogenomics 2009 Dec 10 (12): 1905-13. Lee M T Michael, Chen Chien-Hsiun, Chou Ching-Heng, Lu Liang-Suei, Chuang Hui-Ping, Chen Ying-Ting, Saleem Amir N, Wen Ming-Shien, Chen Jin-Jer, Wu Jer-Yuarn, Chen Yuan-Tso |
Genetic determinants of acenocoumarol and phenprocoumon maintenance dose requirements. European journal of clinical pharmacology 2010 Mar 66 (3): 253-60. Cadamuro Janne, Dieplinger Benjamin, Felder Thomas, Kedenko Igor, Mueller Thomas, Haltmayer Meinhard, Patsch Wolfgang, Oberkofler Hann |
CALU A29809G polymorphism in coronary atherothrombosis: Implications for coronary calcification and prognosis. Annals of medicine 2010 Sep 42 (6): 439-46. Hernández-Romero Diana, Ruiz-Nodar Juan Miguel, Marín Francisco, Tello-Montoliu Antonio, Roldán Vanessa, Mainar Luis, Pérez-Andreu Virginia, Antón Ana I, Bonaque Juan C, Valdés Mariano, Vicente Vicente, González-Conejero Roc |
An evaluation of nine genetic variants related to metabolism and mechanism of action of warfarin as applied to stable dose prediction. Journal of thrombosis and thrombolysis 2010 Oct 30 (3): 358-64. Carlquist John F, Horne Benjamin D, Mower Chrissa, Park James, Huntinghouse John, McKinney Jason T, Muhlestein Joseph B, Anderson Jeffrey |
A polymorphism in the VKORC1 regulator calumenin predicts higher warfarin dose requirements in African Americans. Clinical pharmacology and therapeutics 2010 Apr 87 (4): 445-51. Voora D, Koboldt D C, King C R, Lenzini P A, Eby C S, Porche-Sorbet R, Deych E, Crankshaw M, Milligan P E, McLeod H L, Patel S R, Cavallari L H, Ridker P M, Grice G R, Miller R D, Gage B |
Comparative performance of gene-based warfarin dosing algorithms in a multiethnic population. Journal of thrombosis and haemostasis : JTH 2010 May 8 (5): 1018-26. Lubitz S A, Scott S A, Rothlauf E B, Agarwal A, Peter I, Doheny D, Van Der Zee S, Jaremko M, Yoo C, Desnick R J, Halperin J |
Pharmacogenetics of acenocoumarol in patients with extreme dose requirements. Journal of thrombosis and haemostasis : JTH 2010 May 8 (5): 1012-7. Pérez-Andreu V, Roldán V, López-Fernández M F, Antón A I, Alberca I, Corral J, Montes R, García-Barberá N, Ferrando F, Vicente V, González-Conejero |
Impact of pharmacokinetic (CYP2C9) and pharmacodynamic (VKORC1, F7, GGCX, CALU, EPHX1) gene variants on the initiation and maintenance phases of phenprocoumon therapy. Thrombosis and haemostasis 2011 Jan 105 (1): 169-80. Luxembourg Baete, Schneider Katharina, Sittinger Katja, Toennes Stefan W, Seifried Erhard, Lindhoff-Last Edelgard, Oldenburg Johannes, Geisen Christ |
Prediction of phenprocoumon maintenance dose and phenprocoumon plasma concentration by genetic and non-genetic parameters. European journal of clinical pharmacology 2011 Apr 67 (4): 371-81. Geisen Christof, Luxembourg Beate, Watzka Matthias, Toennes Stefan W, Sittinger Katja, Marinova Milka, von Ahsen Nicolas, Lindhoff-Last Edelgard, Seifried Erhard, Oldenburg Johann |
Copy number variation and warfarin dosing: evaluation of CYP2C9, VKORC1, CYP4F2, GGCX and CALU. Pharmacogenomics 2011 Dec . Scott SA, Patel M, Martis S, Lubitz SA, van der Zee S, Yoo C, Edelmann L, Halperin JL, Desnick RJ |
Genetic and nongenetic factors associated with warfarin dose requirements in Egyptian patients. Pharmacogenetics and genomics 2011 Mar 21 (3): 130-5. Shahin Mohamed Hossam A, Khalifa Sherief I, Gong Yan, Hammad Lamiaa N, Sallam Mohamed T H, El Shafey Mostafa, Ali Shawky S, Mohamed Mohamed-Eslam F, Langaee Taimour, Johnson Julie |
Predicting warfarin dosage in European-Americans and African-Americans using DNA samples linked to an electronic health record. Pharmacogenomics 2012 Mar 13 (4): 407-18. Ramirez Andrea H, Shi Yaping, Schildcrout Jonathan S, Delaney Jessica T, Xu Hua, Oetjens Matthew T, Zuvich Rebecca L, Basford Melissa A, Bowton Erica, Jiang Min, Speltz Peter, Zink Raquel, Cowan James, Pulley Jill M, Ritchie Marylyn D, Masys Daniel R, Roden Dan M, Crawford Dana C, Denny Joshua |
Evaluation of the warfarin-resistance polymorphism, VKORC1 Asp36Tyr, and its effect on dosage algorithms in a genetically heterogeneous anticoagulant clinic. Clinical biochemistry 2012 Apr 45 (6): 397-401. Shuen Andrew Y, Wong Betty Y L, Fu Lei, Selby Rita, Cole David E |
Association of genetic polymorphisms with warfarin dose requirements in Chinese patients. Genetic testing and molecular biomarkers 2013 Dec 17 (12): 932-6. Liang Yundan, Chen Zhiyu, Guo Gang, Dong Xuemei, Wu Chunting, Li He, Wang Tong, Xu Bingyi |
Does CALU SNP rs1043550 contribute variability to therapeutic warfarin dosing requirements? Clinical medicine & research 2013 Jun 11 (2): 73-9. Glurich Ingrid, Berg Richard L, Burmester James |
CALU polymorphism A29809G affects calumenin availability involving vascular calcification. Journal of molecular and cellular cardiology 2015 May 82 218-27. Jover Eva, Marín Francisco, Quintana Míriam, Pérez-Andreu Joaquín, Hurtado José Antonio, Rodríguez Cristina, Martínez-González José, González-Conejero Rocío, Valdés Mariano, Hernández-Romero Dia |
Genetic determinants of variability in warfarin response after the dose-titration phase. Pharmacogenetics and genomics 2016 Sep . Iwuchukwu Otito F, Ramirez Andrea H, Shi Yaping, Bowton Erica A, Kawai Vivian K, Schildcrout Jonathan S, Roden Dan M, Denny Joshua C, Stein C Micha |
Warfarin Dose Model for the Prediction of Stable Maintenance Dose in Indian Patients. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2018 Mar 24 (2): 353-359. Gaikwad Tejasvita, Ghosh Kanjaksha, Avery Peter, Kamali Farhad, Shetty Shrima |
Integrated analysis of genetic variation and gene expression reveals novel variant for increased warfarin dose requirement in African Americans. Journal of thrombosis and haemostasis : JTH 2017 Jan . Hernandez Wenndy, Gamazon Eric R, Aquino-Michaels Keston, Smithberger Erin, O'Brien Travis J, Harralson Arthur F, Tuck Matthew, Barbour April, Cavallari Larisa H, Perera Minoli |
Using Blood and Plasma MicroRNAs as a Non-Invasive Biomarker in Patients with Colorectal Cancer. Clinical laboratory 2018 5 64 (3): 257-262. Stefanescu Horatiu, Muntean Delia, Pilut Ciprian, Diaconu Mircea, Popescu Roxana, Hutanu Delia, Moise Marius, Diana Lighezan, Nitu Razvan, Cherecheanu Alina Popa, Negoita Silvius, Iovan Ciprian V, Ungureanu Emil, Calu Valentin, Ciuca Ioa |
Influence of genetic and non-genetic factors on acenocoumarol maintenance dose requirement in a Tunisian population. European journal of clinical pharmacology 2018 Feb . Ajmi Marwa, Omezzine Asma, Achour Slim, Amor Dorra, Hamdouni Haithem, Ismaïl Fatma Ben Fredj, Rejeb Nabila Ben, Kechrid Chedia Laouani, Boughzela Essia, Bouslama A |
Association between four microRNA binding site-related polymorphisms and the risk of warfarin-induced bleeding complications. EXCLI journal 2019 18 287-299. Hosseindokht Maryam, Boroumand Mohammadali, Salehi Rasoul, Mandegary Ali, Hajhosseini Talasaz Azita, Pourgholi Leyla, Zare Hamed, Ziaee Shayan, Sharifi Mohammadre |
Genetic Associations With Stable Warfarin Dose Requirements in Han Chinese Patients. Journal of cardiovascular pharmacology 2021 5 78 (1): e105-e111. Xu Qingqing, Zhang Suli, Wu Chaoneng, Xiong Yuyu, Niu Jiamin, Li Fengzhen, Zhu Jinhang, Shen Lu, Zhu Bin, Xing Qinghe, He Lin, Chen Luan, Li Mo, Li Hua, Ge Junbo, Qin Shengyi |
Multivariate Risk Analysis of RAS, BRAF and EGFR Mutations Allelic Frequency and Coexistence as Colorectal Cancer Predictive Biomarkers. Cancers 2022 Jun 14 (11): . Ionescu Adriana, Bilteanu Liviu, Geicu Ovidiu Ionut, Iordache Florin, Stanca Loredana, Pisoschi Aurelia Magdalena, Miron Adrian, Serban Andreea Iren, Calu Valent |
Genetic Factors Influencing Warfarin Dose in Han Chinese Population: A Systematic Review and Meta-Analysis of Cohort Studies. Clinical pharmacokinetics 2023 6 62 (6): 819-833. Zinan Zhao, Fei Zhao, Xiang Wang, Deping Liu, Junpeng Liu, Yatong Zhang, Xin Hu, Ming Zhao, Chao Tian, Shujie Dong, Pengfei J |
Identification of cancer-associated fibroblasts signature for predicting the prognosis and immunotherapy response in hepatocellular carcinoma. Medicine 2023 11 102 (45): e35938. Jianzhong Ye, Wen Tian, Bigeng Zheng, Tao Ze |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: